DexCom (DXCM) stock forecast for 2026. Forecast tables and graphs.







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

DexCom (DXCM) stock forecast for 2026

Updated: November 6, 2024 (05:17)

Sector: Healthcare

The share price of DexCom, Inc. (DXCM) now

What analysts predict: $96.33
52-week High/Low: $142 / $62.34

50/200 Day Moving Average: $69.94 / $105.33

This figure corresponds to the Average Price over the previous 50/200 days. For DexCom stocks, the 50-day moving average is the resistance level today.

For DexCom stocks, the 200-day moving average is the resistance level today.

Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the DexCom stock price in 2026. How much will one DexCom share be worth in 2026? Is it worth taking profit / loss on DXCM stock now or waiting? What are analysts' forecasts for DexCom stock?

We forecast DexCom stock performance using neural networks based on historical data on DXCM stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

DexCom, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for DexCom analysts is $96.33. Today 200 Day Moving Average is the resistance level (105.33 $). 50 Day Moving Average is the support level (69.94 $).




Historical and forecast chart of DexCom, Inc. stock

The chart below shows the historical price of DexCom stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the DXCM stock price can be found in the table below.


Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.

Trending Themes in the Healthcare Sector

DexCom (DXCM) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 68.04 66.41 69.40 4.31 %
Feb 72.61 70.87 74.47 4.84 %
Mar 72.03 69.96 76.35 8.38 %
Apr 71.97 67.88 74.97 9.45 %
May 75.02 73.16 76.22 4.02 %
Jun 74.66 72.04 76.63 6.00 %
Jul 73.89 71.46 76.96 7.14 %
Aug 72.88 69.15 76.56 9.67 %
Sep 71.89 68.04 75.51 9.90 %
Oct 68.27 65.76 69.80 5.79 %
Nov 70.02 67.38 74.44 9.48 %
Dec 68.73 67.02 73.13 8.35 %

DexCom information and performance

DexCom Address

6340 SEQUENCE DRIVE, SAN DIEGO, CA, US

Market Capitalization: 27 224 472 000 $

Market capitalization of the DexCom, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DXCM shares in the company outstanding by the market price of one share.

EBITDA: 840 400 000 $

EBITDA of DexCom is earnings before interest, income tax and depreciation of assets.

PE Ratio: 42.24

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.1

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.65

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.157
Quarterly Revenue Growth YOY: 0.02
Trailing PE: 42.24

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 34.25

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.97

Enterprise Value (EV) /Revenue

EV To EBITDA: 28.28

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 390595000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

DexCom price target for 2026 by month


Target values for the price of one DexCom share for Jan 2026.

The weighted average target price per DexCom share in Jan 2026 is: 68.04.
In Jan, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 4.314% volatility is expected.
Pessimistic target level: 66.41
Optimistic target level: 69.40

Target values for the price of one DexCom share for Feb 2026.

The weighted average target price per DexCom share in Feb 2026 is: 72.61.
In Feb, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 4.836% volatility is expected.
Pessimistic target level: 70.87
Optimistic target level: 74.47

Target values for the price of one DexCom share for Mar 2026.

The weighted average target price per DexCom share in Mar 2026 is: 72.03.
In Mar, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 8.377% volatility is expected.
Pessimistic target level: 69.96
Optimistic target level: 76.35

Target values for the price of one DexCom share for Apr 2026.

The weighted average target price per DexCom share in Apr 2026 is: 71.97.
In Apr, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 9.447% volatility is expected.
Pessimistic target level: 67.88
Optimistic target level: 74.97

Target values for the price of one DexCom share for May 2026.

The weighted average target price per DexCom share in May 2026 is: 75.02.
In May, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 4.016% volatility is expected.
Pessimistic target level: 73.16
Optimistic target level: 76.22

Target values for the price of one DexCom share for Jun 2026.

The weighted average target price per DexCom share in Jun 2026 is: 74.66.
In Jun, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 6.002% volatility is expected.
Pessimistic target level: 72.04
Optimistic target level: 76.63

Target values for the price of one DexCom share for Jul 2026.

The weighted average target price per DexCom share in Jul 2026 is: 73.89.
In Jul, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 7.143% volatility is expected.
Pessimistic target level: 71.46
Optimistic target level: 76.96

Target values for the price of one DexCom share for Aug 2026.

The weighted average target price per DexCom share in Aug 2026 is: 72.88.
In Aug, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 9.673% volatility is expected.
Pessimistic target level: 69.15
Optimistic target level: 76.56

Target values for the price of one DexCom share for Sep 2026.

The weighted average target price per DexCom share in Sep 2026 is: 71.89.
In Sep, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 9.901% volatility is expected.
Pessimistic target level: 68.04
Optimistic target level: 75.51

Target values for the price of one DexCom share for Oct 2026.

The weighted average target price per DexCom share in Oct 2026 is: 68.27.
In Oct, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 5.790% volatility is expected.
Pessimistic target level: 65.76
Optimistic target level: 69.80

Target values for the price of one DexCom share for Nov 2026.

The weighted average target price per DexCom share in Nov 2026 is: 70.02.
In Nov, the Positive dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 9.481% volatility is expected.
Pessimistic target level: 67.38
Optimistic target level: 74.44

Target values for the price of one DexCom share for Dec 2026.

The weighted average target price per DexCom share in Dec 2026 is: 68.73.
In Dec, the Negative dynamics for DexCom, Inc. shares will prevail with possible monthly volatility of 8.346% volatility is expected.
Pessimistic target level: 67.02
Optimistic target level: 73.13



Related stocks from Healthcare sector


Disclaimer: